Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05196178
Other study ID # 20211116
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 15, 2021
Est. completion date December 2023

Study information

Verified date November 2021
Source Xuanwu Hospital, Beijing
Contact Jiping Li, MD
Phone 8610-83198899-8630
Email yhljp89@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It's a single-center, prospective, open label clinical study with a 12 months follow-up period, to investigate the therapeutic effect and safety of spinal cord stimulation (SCS) on motor function and gait in patients with pure Hereditary Spastic Paraplegias.


Description:

Pure hereditary spastic paraplegia is a heterogeneous group of genetic disorders characterized by degeneration of the corticospinal tracts, coursing with progressive weakness and spasticity of the lower limbs. The available anti spastic agents and surgical procedures involving anti-spastic systemic drugs, botulinum toxin, intrathecal baclofen, and even selective dorsal rhizotomy have not shown an improvement in muscle strength. Physical rehabilitation alone has shown positive results in short term, but this effect tends to fade away in few months.To date, there are no effective treatments for progressive deficits or disease-modifying therapy for Hereditary spastic paraplegia patients, Spinal cord stimulation is a wellestablished therapy for the treatment of chronic neuropathic pain. Recently, some pilot studies demonstrated encouraging results of SCS in improving motor function. Patients severely affected by spinal cord injury experienced enhancements in leg movements and Parkinson's disease, primary progressive freezing of gait, and multiple system atrophy with predominant parkinsonism patients improved gait performance and freezing of gait after spinal cord stimulation by inducing changes in spinal and brain circuitry function. Some case studies suggest spinal cord stimulation may delay motor worsening and be innovative lines of research for the treatment of spastic paraplegia. However, evidence from larger numbers of subjects is still lacking. The objective of this study is to investigate the therapeutic effect and safety of spinal cord stimulation on motor function and gait in patients with pure hereditary spastic paraplegias It's a single-center, prospective, open label clinical study with a 12 months follow- up period. The intended study population is individuals suffering from pure hereditary spastic paraplegia.Each participant will complete an enrollment/ screening/baseline visit, a spinal cord stimulation implant and activation visit, and a minimum of two follow-up visits, including visit at 3 months and the final study visit at 12months. The participants will proceed to implantation after satisfying implant inclusion and exclusion criteria. Paddle-shaped Spinal cord stimulation electrode with 16 contacts ((AdaptiveStim 39, 565; Medtronic, Minneapolis, USA) will be implanted into the epidural space at the thoracic levels ranging from T10 to T12. Electrode position will be verified by X-ray. The stimulators will be turned on within 1 month after electrode implantation surgery (slightly below sensory threshold). The stimulation parameters could vary freely, but medications will be kept constant during the study period. At the end of month 12, participants will enter the long-term follow-up in which medications and stimulation parameters could vary freely.


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 14 Years to 70 Years
Eligibility Inclusion Criteria: 1. aged between 14 and 70 years 2. patients with pure hereditary spastic paraplegias 3. with progressive weakness and spasticity of the lower limbs, and the gait dysfunction treatable by medication but not adequately controlled with medications 4. Understand potential risk/benefit, consent to the study, study procedures, and agree to complete the study follow-up visits and comply with the study protocol requirements. Exclusion Criteria: 1. cognitive impairment ( MMSE=24), depression (HAMD>24),acute psychosis, active alcohol or drug abuse, terminal illness, and any major medical or psychological histories, diagnoses, conditions, or comorbidities that would interfere with participation in the study per the investigatior's medical judgment 2. surgical or medical contraindications to spinal cord stimulation surgery(e.g. uncontrolled hypertension, advanced coronary artery disease).

Study Design


Intervention

Procedure:
Spinal cord stimulation
Paddle-shaped Spinal cord stimulation electrode with 16 contacts (AdaptiveStim® 39, 565;Medtronic, USA) will be implanted into the epidural space at the thoracic levels ranging from T10 to T12.

Locations

Country Name City State
China Xuanwu Hospital,Capital Medical University Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Xuanwu Hospital, Beijing

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary change in spastic paraplegia rating scale(SPRS) demonstrate the statistically significant improvement in score of spastic paraplegia rating scale(SPRS) from baseline( Off medication) to 12 months(On stimulation/Off medication); The score of SPRS ranges from 0 to 52, higher scores mean a worse outcome . twelve months after surgery
Secondary change in the score of Modified Ashworth Scale demonstrate statistically significant improvement in score of Modified Ashworth Scale from baseline( Off medication) to 12 months(On stimulation/Off medication); The score of Modified Ashworth Scale ranges from 0 to 4, higher scores mean a worse outcome. twelve months after surgery
Secondary change in Activities of Daily Living Scale (ADL) demonstrate statistically significant improvement in score of Activities of Daily Living Scale (ADL) from baseline to 12 months. The score of ADL ranges from 0 to 100, higher scores mean a better outcome. twelve months after surgery
Secondary change in Tinetti Balance and Gait Analysis demonstrate statistically significant improvement in the score of Tinetti balance and gait analysis from baseline( Off medication) to 12 months(On stimulation/Off medication); The score of Tinetti balance and gait ranges from 0 to 28, higher scores mean a better outcome. twelve months after surgery
Secondary change in Berg Balance Scale(BBS) demonstrate statistically significant improvement in score of Berg Balance Scale(BBS) from baseline( Off medication) to On stimulation/Off medication state at 12 months. BBS ranged from 0 to 56, higher scores mean a better outcome. twelve months after surgery
Secondary Clinical Global Impression-Global Improvement Evaluations will performed in off-stimulation and in on-stimulation conditions at 12 months after surgery on the basis of the physician's assessment, as well as on the basis of the patients'selfreported satisfaction. It is rated on a 7-point scale, range from 1(very much improved) through to 7 (very much worse) twelve months after surgery
See also
  Status Clinical Trial Phase
Terminated NCT01208142 - Toe Walker Gait Trial N/A
Completed NCT00934531 - Donepezil and the Risk of Falls in Seniors With Cognitive Impairment N/A
Active, not recruiting NCT03892291 - Objective Dual-task Turning Measures for Return-to-duty Assessments
Terminated NCT04591288 - FES to Improve Gait in CP N/A
Completed NCT02085954 - Evaluation of a Training in the Walking With Exosquelette N/A
Completed NCT05358288 - Effect of Bariatric Surgery on Physical Activity, Gait, Flexibility and Quality of Life
Completed NCT04614857 - Correlation Between Cardiopulmonary Metabolic Cost and Lower Limb Muscle Activity N/A
Completed NCT06227312 - Effect of Whole-body Vibration on the Ankle Joint, Plantar Pressure, and Running Paramethers N/A
Recruiting NCT03801785 - Efficacy of Non-Nutritive Sucking (NNS) on Balance and Gait Measured in 12-42 Month-Old Healthy Children Over 36 Months N/A
Recruiting NCT05277181 - Wearable Technology as an Objective Tool for Measuring Running Gait
Completed NCT05929118 - The Effect of Aquatic Rehabilitation on Knee Function in Anterior Cruciate Ligament Reconstruction Patients. N/A
Recruiting NCT06345625 - Gait and Postural Balance Analysis During Head-motion Perturbed Standing and Walking in Older Adults
Not yet recruiting NCT06289231 - The Use of Artificial Intelligence (AI) for Gait Analysis
Recruiting NCT06400680 - Gait Spine Functional Evaluation Protocol N/A
Not yet recruiting NCT06387459 - Feasibility of Fabric Orthosis for Knee Support in Elderly Gait Improvement N/A
Active, not recruiting NCT05404126 - Balance and Gait in Hearing Impaired Children N/A
Completed NCT05462977 - Rhythmically Entrained Exercise in Community-Dwelling Older Adults N/A
Completed NCT03636971 - Gait Analysis Following Knee Viscosupplementation Phase 2/Phase 3
Not yet recruiting NCT05786690 - The Effect of Microprocessor Controlled Prostheses on Walking Pattern and Energy Consumption
Completed NCT01076413 - Comparison of Two Exercise Interventions to Improve Gait in Older Persons N/A